AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Novel Diabetes Treatment
Summary
Researchers at Purdue University in collaboration with Oklahoma Medical Research Foundation have developed and assayed a series of lead compounds that act as memapsin 1 inhibitors and increase pancreatic beta cell mass. Treatment with these compounds may also be complimented by other therapeutics that increase insulin production, improve glucose homeostasis, or inhibit hyperglucagonemia.
Technology Benefits
Improved glucose homeostasisSpecific enzyme pathway regulation
Technology Application
Medical/HealthcarePharmaceuticals
Detailed Technology Description
Arun GhoshGhosh GroupPurdue Chemistry
Countries
United States
Application No.
None
Country/Region
USA
For more information, please click Here
